Sign in

CIK 0001785279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Metagenomi Therapeutics, Inc.

Sign in to watch
Ticker
MGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
813909017
Phone
(510) 871-4880
Business address
5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
Former names
Metagenomi, Inc., Metagenomi Technologies, LLC
Open-market buys, last 90 days
$23,401
in 1 filing
Open-market sales, last 90 days
$5,107
in 3 filings

Net +$18,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-09-05 Wapnick Pamela Chief Financial Officer Sale −6,265 $2.88 $18K 63,051
2024-04-01 Irish Jian See Remarks Grant or award +70,471 298,933
2024-04-01 Irish Jian See Remarks Grant or award · Stock Option (Right to Buy) +296,308 296,308
2024-04-01 Eckhardt Juergen Director Grant or award · Stock Option (Right to Buy) +78,636 78,636
2024-04-01 Borges Luis Chief Scientific Officer Grant or award +69,316 69,316
2024-04-01 Borges Luis Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +291,450 291,450
2024-04-01 Wein Matthew See Remarks Grant or award +10,397 10,397
2024-04-01 Wein Matthew See Remarks Grant or award · Stock Option (Right to Buy) +43,717 43,717
2024-04-01 Wapnick Pamela Chief Financial Officer Grant or award +69,316 69,316
2024-04-01 Wapnick Pamela Chief Financial Officer Grant or award · Stock Option (Right to Buy) +291,450 291,450
2024-04-01 Noonberg Sarah B. Chief Medical Officer Grant or award +57,763 100,374
2024-04-01 Noonberg Sarah B. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +242,875 242,875
2024-04-01 Bernales Sebastian Director Grant or award · Stock Option (Right to Buy) +78,636 78,636
2024-04-01 Harnest Simon See Remarks Grant or award +11,552 122,664
2024-04-01 Harnest Simon See Remarks Grant or award · Stock Option (Right to Buy) +48,575 48,575
2024-04-01 Delaney Simren See Remarks Grant or award +6,931 93,892
2024-04-01 Delaney Simren See Remarks Grant or award · Stock Option (Right to Buy) +29,145 29,145
2024-04-01 Dere Willard H Director Grant or award · Stock Option (Right to Buy) +78,636 78,636
2024-04-01 Thomas Brian C. Chief Executive Officer Grant or award +118,992 2,496,276
2024-04-01 Thomas Brian C. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +500,323 500,323

Page 4 of 6 · 101 trades